191 related articles for article (PubMed ID: 15167059)
1. Progress in X-linked adrenoleukodystrophy.
Moser H; Dubey P; Fatemi A
Curr Opin Neurol; 2004 Jun; 17(3):263-9. PubMed ID: 15167059
[TBL] [Abstract][Full Text] [Related]
2. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
[TBL] [Abstract][Full Text] [Related]
4. [Endocrine disease in adrenoleukodystrophy].
Girard S; Bruckert E; Turpin G
Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
[TBL] [Abstract][Full Text] [Related]
5. [Adrenoleukodystrophy].
Kálmánchey R; Molzer B; Illés Z; Princzinger A; Sólyom J
Orv Hetil; 1997 Apr; 138(14):867-71. PubMed ID: 9162896
[TBL] [Abstract][Full Text] [Related]
6. Therapy of X-linked adrenoleukodystrophy.
Moser HW
NeuroRx; 2006 Apr; 3(2):246-53. PubMed ID: 16554262
[TBL] [Abstract][Full Text] [Related]
7. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
Moser HW
J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
[TBL] [Abstract][Full Text] [Related]
8. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients.
Moser HW; Loes DJ; Melhem ER; Raymond GV; Bezman L; Cox CS; Lu SE
Neuropediatrics; 2000 Oct; 31(5):227-39. PubMed ID: 11204280
[TBL] [Abstract][Full Text] [Related]
9. Lorenzo's oil may help to prevent ALD symptoms.
Senior K
Lancet Neurol; 2002 Dec; 1(8):468. PubMed ID: 12849323
[No Abstract] [Full Text] [Related]
10. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV
Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218
[TBL] [Abstract][Full Text] [Related]
11. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
[No Abstract] [Full Text] [Related]
13. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
Moser HW
J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
[TBL] [Abstract][Full Text] [Related]
14. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
[TBL] [Abstract][Full Text] [Related]
15. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
16. X-linked adrenoleukodystrophy.
Moser HW; Mahmood A; Raymond GV
Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
[TBL] [Abstract][Full Text] [Related]
17. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of very long-chain fatty acids levels in X-linked adrenoleukodystrophy, treated with haematopoietic stem cell transplantation and Lorenzo's Oil.
Stradomska TJ; Drabko K; Moszczyńska E; Tylki-Szymańska A
Folia Neuropathol; 2014; 52(2):159-63. PubMed ID: 25118901
[TBL] [Abstract][Full Text] [Related]
19. Adrenoleukodystrophy: a link between adrenal insufficiency and school performance.
Bakos JT; Goen P; Ogden A; Brown FR; Karaviti LP
J Clin Endocrinol Metab; 1995 Oct; 80(10):2869-72. PubMed ID: 7559867
[TBL] [Abstract][Full Text] [Related]
20. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy.
Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T
Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
